SHAREHOLDER ALERT: ZUO EGBN MNK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, NY / ACCESSWIRE / July 30, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Zuora, Inc. (NYSE:ZUO)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/zuora-inc-loss-submission-form?prid=2671&wire=1
Lead Plaintiff Deadline: August 13, 2019
Class Period: April 12, 2018 to May 30, 2019

Allegations against ZUO include that: (1) the Company would focus on implementing RevPro for new customers ahead of the deadline to comply with accounting standard ASC 606; (2) as a result, the Company lacked adequate resources to integrate RevPro with the core business; (3) the Company would focus on RevPro integration a year after the acquisition closed; (4) delays in integrating RevPro would materially impact the business; (5) the market for RevPro was limited to customers seeking to implement new accounting standards such as ASC 606; (6) after the deadline for ASC 606 compliance passed, demand for RevPro was reasonably likely to decline; and (7) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Eagle Bancorp, Inc. (NASDAQCM:EGBN)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/eagle-bancorp-inc-loss-submission-form?prid=2671&wire=1
Lead Plaintiff Deadline: September 23, 2019
Class Period: March 2, 2015 to July 17, 2019

Allegations against EGBN include that: (i) Eagle Bancorp’s internal controls and procedures and compliance policies were inadequate; (ii) the foregoing shortcoming created a foreseeable risk of heightened regulatory scrutiny and the need for the Company undertake its own internal investigations; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Mallinckrodt Public Limited Company (NYSE:MNK)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/mallinckrodt-public-limited-company-loss-submission-form?prid=2671&wire=1
Lead Plaintiff Deadline: September 24, 2019
Class Period: February 28, 2018 to July 16, 2019

Allegations against MNK include that: (i) Acthar posed significant safety concerns that rendered it a non-viable treatment for ALS; (ii) accordingly, Mallinckrodt overstated the viability of Acthar as an ALS treatment; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 553962